Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Daxor Corporation

DXRNASDAQ
Healthcare
Medical - Instruments & Supplies
$12.47
$0.16(1.34%)
U.S. Market is Open • 14:19

Daxor Corporation (DXR) Stock Overview

Explore Daxor Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap61.5M
P/E Ratio34.00
EPS (TTM)$0.16
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$13.20
3 Months$15.27
1 Year Target$15.45

DXR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Daxor Corporation (DXR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.17, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $15.45.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 34.00 and a market capitalization of 61.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.81%
5-Day Change
-5.35%
1-Month Change
-9.35%
3-Month Change
-6.08%
6-Month Change
14.33%
Year-to-Date (YTD) Change
-14.97%
1-Year Change
68.88%
3-Year Change
41.98%
5-Year Change
-0.73%
All-Time (Max) Change
28.53%

Contact Information

12123308500
109 Meco Lane, Oak Ridge, TN, 37830

Company Facts

370 Employees
IPO DateJul 25, 1983
CountryUS
Actively Trading

Frequently Asked Questions